Renhe Weilai (Genetalks)
PrivateLast Round
Series A
Jul 1, 2017
Est. Valuation
$406.09M
Total Funding Raised
$36.92M
Company Overview
Renhe Weilai (Genetalks) is a biotechnology company that provides high-performance computing and artificial intelligence solutions for genetic big data analysis and management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renhe Weilai (Genetalks) Comparables
Compare Renhe Weilai (Genetalks) with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentieon Inc. | 79% | |
| MGI | 77% | |
| DNAnexus | 77% | |
Renhe Weilai (Genetalks) Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 1, 2017 |
Renhe Weilai (Genetalks) Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jiawo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2017
$37M round led by Jiawo Capital.
Renhe Weilai (Genetalks) Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Renhe Weilai (Genetalks)'s valuation, stock price, and market status.